HCW BIOLOGICS INC (HCWB) Stock Price, Quote, News and Overview
NASDAQ:HCWB - Nasdaq - US40423R2040 - Common Stock - Currency: USD
HCWB Quote, Performance and Key Statistics
8.2
-0.61 (-6.92%)
The current stock price of HCWB is 8.2 USD. In the past month the price increased by 7.47%. In the past year, price decreased by -81.36%.
HCWB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.69 | 321.39B | ||
| AMGN | AMGEN INC | 13.09 | 146.07B | ||
| GILD | GILEAD SCIENCES INC | 12.96 | 124.92B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 111.67B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.2 | 63.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 36.86B | ||
| ARGX | ARGENX SE - ADR | 95.7 | 34.30B | ||
| ONC | BEIGENE LTD-ADR | 5.61 | 24.34B | ||
| BNTX | BIONTECH SE-ADR | N/A | 22.20B | ||
| NTRA | NATERA INC | N/A | 20.31B | ||
| BIIB | BIOGEN INC | 7.82 | 18.13B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.15B |
Related stock screener links
About HCWB
Company Profile
HCW Biologics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Miramar, Florida and currently employs 36 full-time employees. The company went IPO on 2021-07-20. HCW Biologics Inc. is a clinical-stage biopharmaceutical company. The company is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. The company has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The firm is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.
Company Info
HCW BIOLOGICS INC
2929 N Commerce Pkwy, Miramar, Fl 33025
Miramar FLORIDA US
Employees: 45
Phone: 19548422024
HCW BIOLOGICS INC / HCWB FAQ
What is the stock price of HCW BIOLOGICS INC today?
The current stock price of HCWB is 8.2 USD. The price decreased by -6.92% in the last trading session.
What is the ticker symbol for HCW BIOLOGICS INC stock?
The exchange symbol of HCW BIOLOGICS INC is HCWB and it is listed on the Nasdaq exchange.
On which exchange is HCWB stock listed?
HCWB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HCW BIOLOGICS INC stock?
7 analysts have analysed HCWB and the average price target is 122.4 USD. This implies a price increase of 1392.68% is expected in the next year compared to the current price of 8.2. Check the HCW BIOLOGICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HCW BIOLOGICS INC worth?
HCW BIOLOGICS INC (HCWB) has a market capitalization of 9.18M USD. This makes HCWB a Nano Cap stock.
How many employees does HCW BIOLOGICS INC have?
HCW BIOLOGICS INC (HCWB) currently has 45 employees.
Is HCW BIOLOGICS INC (HCWB) expected to grow?
The Revenue of HCW BIOLOGICS INC (HCWB) is expected to grow by 368.22% in the next year. Check the estimates tab for more information on the HCWB EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HCW BIOLOGICS INC (HCWB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HCWB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HCWB, evaluating the profitability, health, valuation and growth aspects
- HCW BIOLOGICS INC (HCWB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HCW BIOLOGICS INC (HCWB) Sales and EPS estimates to see what analysts future expectations are.
- HCW BIOLOGICS INC (HCWB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HCW BIOLOGICS INC (HCWB) Insider and Institutional Ownership to learn about the owners and their transactions.
- HCW BIOLOGICS INC (HCWB) Stock Chart to make your own analysis
- HCW BIOLOGICS INC (HCWB) Latest news and press-releases to stay up to date.
Does HCW BIOLOGICS INC (HCWB) stock pay dividends?
HCWB does not pay a dividend.
What is the Price/Earnings (PE) ratio of HCW BIOLOGICS INC (HCWB)?
HCW BIOLOGICS INC (HCWB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-28).
HCWB Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to HCWB. When comparing the yearly performance of all stocks, HCWB is a bad performer in the overall market: 97.38% of all stocks are doing better.
HCWB Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to HCWB. HCWB may be in some trouble as it scores bad on both profitability and health.
HCWB Financial Highlights
Over the last trailing twelve months HCWB reported a non-GAAP Earnings per Share(EPS) of -28. The EPS decreased by -66.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.3% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HCWB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to HCWB. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 16.94% and a revenue growth 368.22% for HCWB